학술논문
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer.
Document Type
Article
Source
CA: A Cancer Journal for Clinicians; Sep2023, Vol. 73 Issue 5, p480-515, 36p
Subject
Language
ISSN
00079235
Abstract
Copyright of CA: A Cancer Journal for Clinicians is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)